First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives.
He Q, Liu X, Jiang L, Liu P, Xuan W, Wang Y, Meng R, Feng H, Lv S, Miao Q, Zheng D, Xu Y, Wang M.
He Q, et al. Among authors: wang y, wang m.
Cancer Biol Ther. 2025 Dec;26(1):2441499. doi: 10.1080/15384047.2024.2441499. Epub 2024 Dec 16.
Cancer Biol Ther. 2025.
PMID: 39681355
Free PMC article.
Review.